TREA

98424308 - THI OBI

Follow

Information

  • Trademark
  • 98424308
  • Serial Number
    98424308
  • Filing Date
    February 27, 2024
    a year ago
  • Transaction Date
    March 03, 2025
    6 days ago
  • Status Date
    December 16, 2024
    2 months ago
  • Published for Opposition Date
    August 06, 2024
    7 months ago
  • Location Date
    October 01, 2024
    5 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    OSBORNE, AUDRIANA
  • Attorney Docket Number
    10053784 MEL
    Attorney Name
    Ran He
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
3
Mark Identification
THI OBI
Case File Statements
  • DM0000: The mark consists of The "Thi" is black, the "OBI" is teal. Below OBI is a teal underline.
  • GS0051: Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
  • CC0000: The color(s) black and teal is/are claimed as a feature of the mark.
  • GS0011: Carbide; Cellulose; Glycogen; Glycoprotein; Sulfides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Adjuvants, other than for medical or veterinary purposes; Antioxidants for use in the manufacture of pharmaceuticals; Biochemical catalysts; Biological preparations for use in industry and science; Carbonic hydrates; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Fatty acids for use in pharmaceutical; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of drugs
  • GS0441: Administering vaccines to patients; Alternative medicine services; Cancer screening services; Cultured cell bank services for medical transplantation; Health care; Health care services for treating cancer; Health assessment services; Health counselling; Human tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical screening; Medical treatment using cultured cells; Nursing, medical; Occupational therapy; Providing health information in the field of cancer prevention and treatment; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Regenerative medicine services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services
  • GS0421: Biological research; Biological research and analysis; Chemical analysis; Chemical research; Chemical research and analysis; Chemical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Providing information about medical research in the field of cancer, oncology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies
Case File Event Statements
  • 3/1/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/3/2024 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/26/2024 - 8 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/4/2024 - 11 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/27/2024 - 8 months ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/27/2024 - 8 months ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/27/2024 - 8 months ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/27/2024 - 8 months ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/27/2024 - 8 months ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/17/2024 - 7 months ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/6/2024 - 7 months ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/6/2024 - 7 months ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/1/2024 - 5 months ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/16/2024 - 2 months ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/16/2024 - 2 months ago
    15 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/17/2024 - 2 months ago
    16 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/3/2025 - 6 days ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA